Detalhe da pesquisa
1.
Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Neurol Sci
; 44(6): 1905-1915, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745300
2.
Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4-immunoglobulin G-seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial.
Mult Scler
; 28(6): 925-932, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595983
3.
An assessment on the use of infra-scanner for the diagnosis of the brain hematoma in head trauma.
Am J Emerg Med
; 55: 174-179, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366587
4.
A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab.
Int J Neurosci
; 129(6): 619-622, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30430892
5.
Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study.
Mult Scler Relat Disord
; 71: 104548, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827877
6.
Concurrent Dawson's Fingers and Area Postrema Lesion in a Mixed Neuroimmune Disorder.
Can J Neurol Sci
; 44(4): 452-454, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28091334
7.
Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Neurol Ther
; 11(4): 1553-1569, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902484
8.
Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis.
Mult Scler Int
; 2022: 9388813, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36187599
9.
Inebilizumab for treatment of neuromyelitis optica spectrum disorder.
Neurodegener Dis Manag
; 11(5): 341-352, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486379
10.
Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?
Mult Scler Relat Disord
; 52: 102964, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915519
11.
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial.
Ann Clin Transl Neurol
; 8(3): 711-715, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621404
12.
The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease.
Am J Med Genet B Neuropsychiatr Genet
; 147B(2): 216-22, 2008 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17918239
13.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Contemp Clin Trials
; 50: 166-77, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521810
14.
Identification of proteins in human substantia nigra.
Proteomics Clin Appl
; 2(5): 776-82, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21136874